These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33925912)

  • 1. Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients.
    Kawasuji H; Tsuji Y; Ogami C; Kaneda M; Murai Y; Kimoto K; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y
    Antibiotics (Basel); 2021 Apr; 10(5):. PubMed ID: 33925912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients.
    Kawasuji H; Tsuji Y; Ogami C; Kimoto K; Ueno A; Miyajima Y; Kawago K; Sakamaki I; Yamamoto Y
    BMC Pharmacol Toxicol; 2021 Mar; 22(1):13. PubMed ID: 33663616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A standard dose of linezolid puts patients with hepatic impairment at risk of overexposure.
    Liao R; Dong Y; Chen L; Wang T; Li H; Dong H
    Eur J Clin Pharmacol; 2023 Jan; 79(1):149-157. PubMed ID: 36434292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?
    Pea F; Cojutti PG; Baraldo M
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):303-308. PubMed ID: 28419737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients.
    Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
    Int J Antimicrob Agents; 2014 Sep; 44(3):242-7. PubMed ID: 25108880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study.
    Cojutti PG; Merelli M; Bassetti M; Pea F
    J Antimicrob Chemother; 2019 Dec; 74(12):3588-3595. PubMed ID: 31504570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of high plasma concentrations of linezolid in Taiwanese adult patients- therapeutic drug monitoring in improving adverse drug reactions.
    Cheng CN; Wu CC; Kuo CH; Wang CC; Wang JT; Lin YT; Jhang RS; Lin SW
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):466-475. PubMed ID: 32600864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of Linezolid Dosing in Renal Impairment To Improve Safety.
    Crass RL; Cojutti PG; Pai MP; Pea F
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose optimisation of linezolid in critically ill patients based on a population pharmacokinetic model: A two-centre prospective interventional study.
    Shi L; Zhang Y; Duan L; Huang L; Li J; Lu J; Zhuang Z; Yuan Y; Feng Z; Sun J; Liu X; Zhou Q; Xue H; Xu J; Tang L
    Int J Antimicrob Agents; 2023 Aug; 62(2):106881. PubMed ID: 37301313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study.
    Kovacevic P; Milakovic D; Kovacevic T; Barisic V; Dragic S; Zlojutro B; Miljkovic B; Vucicevic K; Rizwan Z
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38713258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical efficacy and safety of vancomycin compared with linezolid for the treatment of neonatal gram-positive bacterial sepsis].
    Tang L; Fang J; Wang SN; Weng XH; Li JJ; Shang EN
    Zhonghua Er Ke Za Zhi; 2016 Sep; 54(9):686-91. PubMed ID: 27596084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients.
    Cojutti P; Pai MP; Pea F
    Clin Pharmacokinet; 2018 Aug; 57(8):989-1000. PubMed ID: 29080937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid-Induced Thrombocytopenia in Patients with Renal Impairment: A Case Series, Review and Dose Advice.
    Laarhuis SRE; Kerskes CHM; Nijziel MR; van Wensen RJA; Touw DJ
    Drugs R D; 2024 Mar; 24(1):109-115. PubMed ID: 38480595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial trough concentration may be beneficial in preventing linezolid-induced thrombocytopenia.
    Komatsu T; Nakamura M; Uchiyama K; Inoue G; Sakanoue K; Kawamura A; Hiratsuka K; Takayama Y; Takaso M; Atsuda K
    J Chemother; 2022 Oct; 34(6):375-380. PubMed ID: 35209803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bicytopenia, especially thrombocytopenia in hemodialysis and non-hemodialysis patients treated with linezolid therapy.
    Kato H; Hamada Y; Hagihara M; Hirai J; Yamagishi Y; Matsuura K; Mikamo H
    J Infect Chemother; 2015 Oct; 21(10):707-12. PubMed ID: 26231318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment.
    Keutzer L; Mockeliunas L; Sturkenboom MGG; Bolhuis MS; Akkerman OW; Simonsson USH
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.
    Nukui Y; Hatakeyama S; Okamoto K; Yamamoto T; Hisaka A; Suzuki H; Yata N; Yotsuyanagi H; Moriya K
    J Antimicrob Chemother; 2013 Sep; 68(9):2128-33. PubMed ID: 23625638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and validation of a risk prediction model incorporating concentrations of linezolid and its metabolite PNU142300 for linezolid-induced thrombocytopenia.
    Xu J; Lu J; Yuan Y; Duan L; Shi L; Chen F; Cao Y; Xu G; Feng Z; Li L; Xue H; Sun J; Zhou Q; Zhuang Z; Tang L
    J Antimicrob Chemother; 2023 Aug; 78(8):1974-1981. PubMed ID: 37341139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute-on-chronic liver failure alters linezolid pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study.
    Tikiso T; Fuhrmann V; König C; Jarczak D; Iwersen-Bergmann S; Kluge S; Wicha SG; Grensemann J
    Ann Intensive Care; 2023 Sep; 13(1):83. PubMed ID: 37698659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.